Tracking Cross-Validated Estimates of Prediction Error as Studies Accumulate
随研究累积追踪交叉验证预测误差估计AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要关注异质研究中的通用分类验证,未涉及宏观预测或金融收益预测。
反馈分类问题随研究累积追踪交叉验证预测误差估计AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
In recent years, “reproducibility” has emerged as a key factor in evaluating x applications of statistics to the biomedical sciences, for example, learning predictors of disease phenotypes from high-throughput “omics” data. In particular, “validation” is undermined when error rates on newly acquired data are sharply higher than those originally reported. More precisely, when data are collected from m “studies” representing possibly different subphenotypes, more generally different mixtures of subphenotypes, the error rates in cross-study validation (CSV) are observed to be larger than those obtained in ordinary randomized cross-validation (RCV), although the “gap” seems to close as m increases. Whereas these findings are hardly surprising for a heterogenous underlying population, this discrepancy is then seen as a barrier to translational research. We provide a statistical formulation in the large-sample limit: studies themselves are modeled as components of a mixture and all error rates are optimal (Bayes) for a two-class problem. Our results cohere with the trends observed in practice and suggest what is likely to be observed with large samples and consistent density estimators, namely, that the CSV error rate exceeds the RCV error rates for any m, the latter (appropriately averaged) increases with m, and both converge to the optimal rate for the whole population.